Article History
Accepted: 18 January 2023
First Online: 25 February 2023
Declarations
:
: Dr McDowell has received speaker’s honoraria from GSK and support for attending meetings from Cheisi, outside the submitted work. Dr. Busby reports grants from Astrazeneca, personal fees from Nuvoair, outside the submitted work. Prof Heaney has received payment honoraria from LGH has received non-financial support from GlaxoSmithKline during the conduct of the study; has received grants from Amgen, AstraZeneca, Medimmune, Janssen, Novartis, Roche/Genentech, GlaxoSmithKline, Boehringer Ingelheim, Aerocrine, and Vitalograph; is the lead for the UK MRC Consortium for Stratified Medicine in Severe Asthma in partnership with Novartis, Hoffman la Roche/Genentech, Evelo Biosciences, Sanofi, GlaxoSmithKline, AstraZeneca, Teva, Theravance, and Circassia; has received travel funding support for international respiratory meetings (institution remunerated) from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Napp Pharmaceutical; has received project grant funding from Medimmune, Novartis UK, Roche/Genentech, and GlaxoSmithKline; and has received funding for clinical trials (institution remunerated) from AstraZeneca, GlaxoSmithKline, Schering Plough, Synairgen, Novartis, and Roche/Genentech. These are outside of the submitted work.
: This article does not contain new study data with human or animal studies performed by any of the authors.